Our results suggest that the protective effect of IKK 16 in experimental sepsis is (at least in part) attributable to an anti-inflammatory and endothelial protective effect mediated by inhibition of inflammation through NF-κB, subsequent decreased iNOS expression and interestingly the activation of the well-known Akt-eNOS survival pathway. This evidence concerns the gene NFKB1 and Sepsis.